Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Gold.com (GOLD) trades at a low EV relative to free cash flow, modest leverage and a dividend yield close to 1.9%. Recent headlines around major miners - including Barrick's portfolio reshuffle and potential US redomiciliation - have pushed market participants to price Nevada-related upside as already realized. That optimism has flowed into the pre…
ProMIS Neurosciences has appointed Ivana Rubino, Ph.D., a seasoned executive with extensive experience at Biogen and Roche, as Chief Commercial Officer. This move strengthens ProMIS' commercial and development leadership as the company progresses with its Alzheimer's disease antibody therapy PMN310, moving toward expected 12-month topline data in Q…
Zenas BioPharma, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, plans to host a virtual R&D event on October 27, 2026. The event will feature updates on their pipeline products including obexelimab and ZB021, with expert insights on the clinical landscape. The company is advancing two late-stage molecule…
Ocugen, Inc., a US-based biotechnology company specializing in novel gene therapies for blindness diseases, announced the appointment of Jolanda Crombach as General Manager of its newly established European affiliate in Amsterdam. This expansion aims to support upcoming Phase 3 clinical trials, marketing authorization submissions, and potential com…
Octave Intelligence plc will release its third quarter 2026 financial results on November 12, 2026, and hold a conference call to discuss the results and business outlook. The company is a global leader in mission-critical software for facilities and infrastructure, serving industries requiring high performance, safety, and reliability.
Xanadu Quantum Technologies announced a strategic multi-year partnership with GlobalFoundries to industrialize and scale the production of advanced photonic components essential for utility-scale quantum computing. Leveraging GlobalFoundries' 300 mm manufacturing line in Malta, NY, the collaboration focuses on deploying Xanadu's ultra-low loss sili…
ServiceTitan announced at Pantheon 2026 the nationwide availability of its AI-powered Max package for residential contractors, a pilot for commercial and roofing sectors, and the launch of the Atlas mobile app and Homh demand generation platform. These innovations aim to automate workflows, enhance business insights, and connect contractors with co…
OKYO Pharma has initiated patient enrollment in the Phase 3 NEPTUNE clinical trial evaluating urcosimod, a novel investigational treatment for neuropathic corneal pain (NCP), a severe and debilitating ocular condition with no FDA-approved therapies. The multicenter registrational study is underway across multiple US and European sites aiming to est…
Shopify Inc. will release its financial results for the third quarter ended September 30, 2026, on November 3, 2026, before market open. Management will host a conference call to discuss the results, accessible via webcast on the company's investor relations website.
MapLight Therapeutics celebrates co-founder Dr. Karl Deisseroth's receipt of the 2026 Nobel Prize in Physiology or Medicine for the development of optogenetics, a foundational technology that inspired the company’s circuit-based drug discovery approach. MapLight utilizes optogenetics to identify neural circuits linked to CNS disorders and develop t…
SNDL Inc., a major Canadian cannabis and liquor retailer listed on NASDAQ and CSE, announced the immediate resignation of its board director Carlo Cannell. The company expressed gratitude for his contributions. This leadership change occurs without additional operational updates.
Auddia Inc. has canceled its October 7 shareholder meeting originally scheduled to approve a merger with Thramann Holdings due to insufficient votes from shareholders on the original record date. The company cites significant growth in the strategic value of LT350, a Thramann subsidiary deploying innovative distributed AI datacenter infrastructure,…
The Simply Good Foods Company, traded on NASDAQ as SMPL, announced it will release its fourth quarter fiscal year 2026 financial results on October 27, 2026. The announcement includes details of a live conference call featuring senior executives and provides information for investor participation. The company is recognized as a leader in nutritiona…
Kamada Ltd., a biopharmaceutical company listed on NASDAQ and the Tel Aviv Stock Exchange, announced the launch of two new biosimilar products in Israel: Ustekinumab-Kamada and Enoxaparin-Kamada. These launches expand its biosimilar portfolio, which currently includes two other products. Kamada expects biosimilar sales to grow from $4 million in 20…
Regeneron Pharmaceuticals announced multiple presentations at the European Society for Medical Oncology (ESMO) Congress 2026 highlighting advances across several cancers including cutaneous squamous cell carcinoma, non-small cell lung cancer, ovarian cancer, melanoma, and cancer-associated thrombosis. Key data include Phase 3 survival outcomes for …
Medifast, Inc. (NYSE: MED) highlights the challenges of weight regain after weight loss and introduces its Trilivy™ metabolic health system designed to address key drivers of weight regain. Trilivy targets metabolic dysfunction by preserving lean mass, reducing visceral fat, and developing long-term healthy habits through coaching and behavioral sc…
CTO Realty Growth, Inc. has announced the acquisition of Summit Woods Crossing, a 545,000-square-foot open-air power center in the Kansas City metro area, for $103 million. The property is nearly fully occupied and located in a strong market with high visitation and demographic appeal. This acquisition aligns with CTO's investment strategy of purch…
Uber is trading like a mature business while still growing revenue and generating large free cash flow. At $70, the stock offers a reasonable entry for a mid-term swing trade that bets on accelerating margin conversion and short-covering. The plan: long at $70.00, stop $63.00, target $85.00 over 45 trading days.
Bullish, a US-listed global digital asset platform, released its September 2026 monthly metrics covering spot and derivatives trading volume, average trading spreads, and volatility for key cryptocurrencies Bitcoin and Ethereum. The company provides institutionally focused regulated market infrastructure and information services, including its exch…
Descartes Systems Group introduced the Agent Control Plane, a significant AI advancement that coordinates AI agents across applications and trading partners to manage multi-step supply chain workflows, reducing manual tasks and improving operational efficiency. Debuted at their Innovation Forum with record attendance, this innovation leverages Desc…
Telix Pharmaceuticals has commenced the first U.S. commercial doses of Pixclara® (floretyrosine F 18), the only FDA-approved radiopharmaceutical PET imaging drug for glioma. The drug aids differentiation of recurrent or progressive glioma from treatment-related changes in adult and pediatric patients, addressing a significant unmet medical need. Ma…
Bimergen Energy, a U.S.-based renewable energy infrastructure developer focused on battery energy storage systems, reported its first-ever revenue and GAAP profitability in Q2 2026. The company achieved $7.9 million in revenue with a net income of $1.6 million. It also completed a $13.6 million public offering and uplisted to the NYSE American, str…
Quoin Pharmaceuticals announced the acceptance of a peer-reviewed paper introducing QRX003, an investigational topical lotion for Netherton Syndrome, in Dermatology and Therapy. The paper details the drug's mechanism, a positive pediatric compassionate use case by Professor Alan Irvine, and promising interim Phase 2/3 study results showing clinical…
Parsons Corporation (NYSE: PSN) will report its financial results for the third quarter of 2026 on October 28, prior to market open. The company will hold a live webcast conference call at 8 a.m. ET to discuss the results and guidance, followed by a Q&A session. A replay will be available for one year on the company website.
Range Resources Corporation announced that it will release its third quarter 2026 financial results on October 27, 2026, after the NYSE closes. A conference call to discuss these results is scheduled for October 28, 2026, with a live webcast available on the company's website.
